These campaigns start thinking about a transition of power. Guest it is an interesting history. Until 2010 there was no legal requirement for campaigns to prepare. In 2010 the president ial transition act passed. It provided that it was not just something they could do, it was a responsibility. Of candidates who are representing major parties to organize transitions. So, transitions generally start as early as april. Certainly by may, because there is just too much to do in organizing the National Government to do it in 75 days between the election and inauguration. It is a quite surprisingly sophisticated, can be, operation. Host what does it entail . Guest there are really four responsibilities. The first is to prepare to put a team on the field, if you will. Organize a white house staff, a cabinet to fill the most important senateconfirmed positions. They have to be cleared. Getting a running start is important. The Second District the second is to prepare the first 100 or 200 days
Policy speech. The city faces rising infection rates and a clamp from beijing. Joe biden names his Foreign Policy and Security Team as he with to calm Relations International friends and foes. He says america is back ready to lead. Haidi lets look at the set up at the start of trading. We are seeing some green shoots at the open, about. 4 higher. Global stocks as well as asian stocks continuing to be on a tear. We are watching keenly for developments in kiwi assets, given we had the rbc releasing its semiannual stability report. This is pushing the kiwi dollar higher. U. S. Ashed through . 70 yesterday and we are seeing expectations of negative rates dissipate even further. Unlovedtors rotate into areas, it may not mean the end of things that have been successful so far. John praveen is Portfolio Manager for qma. He joins us on the phone from new york. We are talking about what happens to big tech given the rotation trade gaining a more solid footing. Is it the behavioral changes, chan
Youre expecting here in the coming days and week. What we should be watching for this week. Hanks for having me, john. That makes two of us as far as trying to keep on top of everything. As far as the current state of play, these past three weeks we have seen three crucial positive readouts of data from leading programs. The first came from pfizer, the second came from moderna, and the third one this morning just came from astrazeneca and the team at oxford. These are three leading vaccine front runners, all three in late stage studies appear to be effective, the first to 95 effective in preventing covid19. Thatnity is expected to do late november, early december. That will set up an fda decision, all eyes turning to the agency to see how quickly they can approve it and for what subgroups of the population. Vaccineing on in the phase, but there is a lot going on and muchneeded positive news when you think about the surge that we have seen in cases, hospitalizations, and deaths. The fda
Washington ramps up pressure on beijing. Goldman sachs raises billions for a new fund to focus on private equity. The move comes amid rising interest in secondary investing. Haidi lets look at what the day has in store at the sydney open. We are expected a muted start to trading in asia after downward pressure coming from the u. S. Session overnight. Restrictions continue to take place to curb the the Coronavirus Spread we are starting to see accelerate again, even as we get further good news on the vaccine front. Trading marginal. The u. S. Dollar held to the lowest we have seen since april 2018. We are also seeing the aussie dollar on the back foot. Nikkei futures look like they will see a muted start to trading. Shery lets get started with good news on the vaccine front. Pfizer says final Data Analysis shows its covid shot is 95 effective. The ceo of its german partner told bloomberg about plans for mass production. Our goal is to supply up to 50 million doses by 2020 which andd go
As far as the current state of play, these past three weeks we have seen three crucial positive readouts of data from leading programs. The first came from pfizer, the second came from moderna, and the third one this morning just came from astrazeneca and the team at oxford. These are three leading vaccine front runners, all three in late stage studies appear to be effective, the first to 95 effective in preventing covid19. Thatnity is expected to do late november, early december. That will set up an fda decision, all eyes turning to the agency to see how quickly they can approve it and for what subgroups of the population. Vaccineing on in the phase, but there is a lot going on and muchneeded positive news when you think about the surge that we have seen in cases, hospitalizations, and deaths. The fda approval, how quickly could they approve it, and what could keep them from being approved, and how is the fda ensuring confidence in the public in the safety of these vaccines . Guest i